NASDAQ: MLYS - Mineralys Therapeutics, Inc.

Yield per half year: +13%
Sector: Healthcare

Share chart Mineralys Therapeutics, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About

Mineralys Therapeutics, Inc., биофармацевтическая компания клинической стадии, которая разрабатывает методы лечения гипертонии и связанных с ней сердечно-сосудистых заболеваний. Кандидатом на клиническую стадию является лорундростат, запатентованный пероральный высокоселективный ингибитор альдостеронсинтазы для лечения пациентов с неконтролируемой или резистентной гипертензией. Компания была зарегистрирована в 2019 году и имеет штаб-квартиру в Радноре, штат Пенсильвания.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

Цена ао 14.32
Сайт https://mineralystx.com
ISIN US6031701013
EV/EBITDA -1.05
P/BV 1.22
EBITDA -0.0029
Число акций ао 0.03619 млрд
Валюта usd
IPO date 2023-02-10
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Change price per day: 0% (13.56)
Change price per week: -0.7321% (13.66)
Change price per month: +15.31% (11.76)
Change price per 3 month: -7% (14.58)
Change price per half year: +13% (12)
Change price per year: +49.67% (9.06)
Change price per year to date: +127.52% (5.96)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 1.22 9
P/E 0 0
EV/EBITDA -2.91 0
Total: 3.5

Efficiency

Title Value Grade
ROA, % -28.57 0
ROE, % -29.81 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA 0 10
Total: 9.8

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 2465.36 10
Yield EPS, % 2165.42 10
Total: 8
More

Institutions Volume Share, %
Catalys Pacific, LLC 9194579 18.53
Samsara BioCapital, LLC 4519361 9.11
RA Capital Management, L.P. 3178476 6.4
Adams Street Partners, LLC 2302329 4.64
Braidwell LP 2023900 4.08
SR One Capital Management, LP 1794600 3.62
Blackrock Inc. 1394774 2.81
Rock Springs Capital Management, LP 1167492 2.35
Laurion Capital Management, LP 1156068 2.33
Vanguard Group Inc 977980 1.97

ETF Share, % Profitability for 1 year, % Dividends, %
Avantis U.S Small Cap Equity ETF 0.02342 35.517080018718 1.68271
Virtus LifeSci Biotech Clinical Trials ETF 0.73121 77.329244365683 0.33
ProShares Ultra Nasdaq Biotechnology 0.03856 58.954326923077 0.85651
ProShares Hedge Replication ETF 0.00203 6.8665973306333 1.47892
Humankind US Stock ETF 0.00395 22.971795629061 1.99919
Invesco Nasdaq Biotechnology ETF 0.05795 29.399255715045 0.8565
iShares Micro-Cap ETF 0.08456 43.316995205115 1.54048
iShares Russell 2000 Growth ETF 0.0045 47.42032299557 0.6026
iShares Russell 3000 ETF 0.00049 37.942616648456 1.43482
Schwab U.S. Small-Cap ETF 0.00693 -30.367553865653 1.51433
Schwab U.S. Broad Market ETF 0.00067 -53.970149253731 1.43354
ProShares UltraPro Russell2000 0.00722 125.96465921385 1.47873
Vanguard Russell 3000 ETF 0 38.467141890837 1.43817
Vanguard Russell 2000 Growth ETF 0.01 46.764050831914 0.60264
Vanguard Russell 2000 ETF 0.01 41.410408042578 1.48801
Principal Healthcare Innovators ETF 0.05639 631.79771324797 0.8416
Future Tech ETF 0.05639 412.888593871 0.8416



Head Job title Payment Year of birth
Mr. Jon Congleton CEO & Director 428.87k 1963 (61 year)
Mr. Adam Scott Levy CFO & Secretary 409.17k 1978 (46 years)
Dr. Brian Taylor Slingsby M.D., M.P.H., Ph.D. Founder & Executive Chairman N/A 1977 (47 years)
Dr. Robert McKean Ph.D. Senior Vice President of CMC N/A
Ms. Cindy Berejikian Executive Vice President of Operations N/A
Ms. Danielle Bradbury Senior Vice President of Quality Assurance N/A
Mr. Jeffrey N. Fellows Senior Vice President of Regulatory Affairs N/A
Ms. Jessica Ibbitson Senior Vice President of Clinical Operations N/A
Dr. David M. Rodman M.D. Chief Medical Officer 423.66k 1955 (69 years)
Ms. Sarah Foster Vice President of Human Resources N/A

Address: United States, Radnor. PA, 150 N. Radnor Chester Rd. - open in Google maps, open in Yandex maps
Website: https://mineralystx.com